000 | 01954 a2200529 4500 | ||
---|---|---|---|
005 | 20250513204444.0 | ||
264 | 0 | _c20000515 | |
008 | 200005s 0 0 eng d | ||
022 | _a0007-1188 | ||
024 | 7 |
_a10.1038/sj.bjp.0703144 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDing, H | |
245 | 0 | 0 |
_aPotassium- and acetylcholine-induced vasorelaxation in mice lacking endothelial nitric oxide synthase. _h[electronic resource] |
260 |
_bBritish journal of pharmacology _cMar 2000 |
||
300 |
_a1194-200 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAcetylcholine _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aApamin _xpharmacology |
650 | 0 | 4 |
_aArteries _xdrug effects |
650 | 0 | 4 |
_aBarium _xpharmacology |
650 | 0 | 4 |
_aBiological Factors _xpharmacology |
650 | 0 | 4 |
_aCharybdotoxin _xpharmacology |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 |
_aMesenteric Veins _xdrug effects |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Knockout |
650 | 0 | 4 |
_aMuscle Relaxation _xdrug effects |
650 | 0 | 4 |
_aMuscle, Smooth, Vascular _xdrug effects |
650 | 0 | 4 |
_aNitric Oxide Synthase _xantagonists & inhibitors |
650 | 0 | 4 | _aNitric Oxide Synthase Type II |
650 | 0 | 4 | _aNitric Oxide Synthase Type III |
650 | 0 | 4 |
_aNitroarginine _xpharmacology |
650 | 0 | 4 |
_aOuabain _xpharmacology |
650 | 0 | 4 |
_aPeptides _xpharmacology |
650 | 0 | 4 |
_aPotassium _xpharmacology |
650 | 0 | 4 | _aPotassium Channel Blockers |
650 | 0 | 4 | _aPotassium Channels |
650 | 0 | 4 | _aPotassium Channels, Inwardly Rectifying |
650 | 0 | 4 |
_aSodium-Potassium-Exchanging ATPase _xantagonists & inhibitors |
650 | 0 | 4 | _aKcnj10 Channel |
700 | 1 | _aKubes, P | |
700 | 1 | _aTriggle, C | |
773 | 0 |
_tBritish journal of pharmacology _gvol. 129 _gno. 6 _gp. 1194-200 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bjp.0703144 _zAvailable from publisher's website |
999 |
_c10679092 _d10679092 |